Antisense & RNAi Therapeutics Market Size Worth $1.81 Billion By 2025
Antisense & RNAi Therapeutics Industry Overview The global antisense & RNAi therapeutics market size is expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Development in biological vectors and nanotechnology and rising external funding to conduct clinical studies pertaining to introduction of novel drug moieties play a vital role in the process of product development and fuel growth in this market. Antisense & RNAi Therapeutics Market Segmentation Grand View Research has segmented the global antisense & RNAi therapeutics market on the basis of technology, application, route of administration, and region: Based on the Technology Insights, the market is segmented into RNA Interference, Antisense RNA. Antisense RNA has led the market in terms of revenue generation. These molecules are being tested to prevent disease onset and to halt the disease progression. Recent studies...